Early Access — free while we kick the tires
EdgarHawk

CNTB Connect Biopharma Holdings Ltd Insider Trading

Latest: Director Bought $372K of Shares · May 2026
1 filing analyzed · Latest 2026-06-02
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
June 2026
2026-06-02
medium
James Huang Buy
150,000 shares
$371,610
@ $2.48
Significance 4/10

Director James Huang buys 150,000 shares of CNTB at $2.48; stock now $2.15, down -43.7% from 52-week high amid revenue collapse of -99.8%.

James Huang (Director) purchased 150,000 shares at $2.48 on 2026-05-29, increasing his holdings from 13,160,000 to 13,310,000 shares. The stock has since declined to $2.15 (current price), representing a -13.0% drop over the past 30 days and -17.0% over 90 days. Most notably, the company's fundamentals are severely deteriorated: annual revenue growth stands at -99.8%, quarterly revenue is just $169,000.00, and the company posted a net loss of $-19,398,000.00 in its latest full fiscal year. Huang's prior buy at this ticker on 2026-03-31 produced 90-day returns of -32.2%, and across his broader cross-ticker track record (1 prior buy), his average 90-day return is -32.2% with a 0.00% win rate. This new purchase occurs against ongoing deterioration in both stock price and fundamental metrics.

Get alerts for CNTB

Add CNTB to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access